Immune Profile of Saliva and Serum of Patients With Primary Sjögren´s Syndrome | MicrobiomeTrials← Back to trialsNCT03711214
Immune Profile of Saliva and Serum of Patients With Primary Sjögren´s Syndrome
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2018-12-01Est. Completion: 2021-10-13
Enrollment target: 80 participants Locations- Hospital das Clínicas da Faculdade de Medicina da USP, São Paulo, São Paulo, Brazil
- Rheumatology Division of Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo, São Paulo, São Paulo, Brazil
- Hospital das Clínicas da Faculdade de Medicina da USP, São Paulo, Brazil
Other microbiome trials you might be interested in
Primary Sjögren's Syndrome
This is a Phase 2b, multicenter, randomized, double-blinded, placebo-controlled study to assess the efficacy and safety …
Covina, United StatesEst. completion Jul 2028
Sjögren´s Disease
The purpose of this study is to demonstrate the efficacy and safety of ianalumab (VAY736) 300 mg administered subcutaneo…
Peoria, United StatesEst. completion Aug 14, 2029
Phase 2
Recruiting
To evaluate efficacy, safety, and tolerability of DDY391 up to 52 weeks in participants with Sjögren's disease (SjD) and…
Tampa, United StatesEst. completion Feb 19, 2029